| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heme Oxygenase-1 | 33 | 2014 | 365 | 3.530 |
Why?
|
| Heme Oxygenase (Decyclizing) | 22 | 2004 | 166 | 3.020 |
Why?
|
| Sepsis | 15 | 2024 | 2601 | 2.600 |
Why?
|
| Mesenchymal Stem Cells | 11 | 2024 | 1671 | 2.410 |
Why?
|
| HMGA1a Protein | 11 | 2021 | 63 | 2.330 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 7 | 2023 | 507 | 1.980 |
Why?
|
| Endotoxemia | 12 | 2018 | 198 | 1.880 |
Why?
|
| Muscle, Smooth, Vascular | 34 | 2020 | 1493 | 1.850 |
Why?
|
| Carbon Monoxide | 9 | 2024 | 552 | 1.840 |
Why?
|
| Phagocytosis | 9 | 2024 | 1530 | 1.720 |
Why?
|
| Nitric Oxide Synthase | 17 | 2004 | 911 | 1.590 |
Why?
|
| Syndecan-2 | 5 | 2022 | 23 | 1.340 |
Why?
|
| Paracrine Communication | 2 | 2024 | 278 | 0.980 |
Why?
|
| Muscle Proteins | 13 | 2024 | 1165 | 0.980 |
Why?
|
| Lipopolysaccharides | 19 | 2021 | 2215 | 0.940 |
Why?
|
| Cyclooxygenase 2 | 5 | 2011 | 599 | 0.930 |
Why?
|
| Myosin-Light-Chain Kinase | 9 | 2024 | 104 | 0.920 |
Why?
|
| Autophagy | 4 | 2024 | 1351 | 0.880 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2023 | 843 | 0.860 |
Why?
|
| Genes, Dominant | 6 | 2021 | 856 | 0.850 |
Why?
|
| Macrophages | 14 | 2024 | 5796 | 0.840 |
Why?
|
| Proto-Oncogene Proteins c-ets | 5 | 2014 | 314 | 0.790 |
Why?
|
| Promoter Regions, Genetic | 32 | 2011 | 5801 | 0.780 |
Why?
|
| Nitric Oxide Synthase Type II | 13 | 2009 | 515 | 0.760 |
Why?
|
| Chemokine CXCL12 | 2 | 2021 | 457 | 0.750 |
Why?
|
| Mice | 89 | 2024 | 82017 | 0.750 |
Why?
|
| Gene Expression Regulation, Enzymologic | 12 | 2009 | 1169 | 0.730 |
Why?
|
| High Mobility Group Proteins | 6 | 2001 | 179 | 0.720 |
Why?
|
| Distamycins | 4 | 2010 | 10 | 0.720 |
Why?
|
| Animals | 152 | 2024 | 169337 | 0.710 |
Why?
|
| Interleukin-1 | 10 | 2000 | 1251 | 0.690 |
Why?
|
| Lung | 31 | 2024 | 10089 | 0.690 |
Why?
|
| Oxidative Stress | 12 | 2024 | 3139 | 0.680 |
Why?
|
| Mitochondrial Diseases | 1 | 2023 | 344 | 0.680 |
Why?
|
| Transforming Growth Factor beta | 12 | 2018 | 2003 | 0.640 |
Why?
|
| Neutrophils | 9 | 2024 | 3785 | 0.600 |
Why?
|
| Fibrin | 1 | 2021 | 514 | 0.590 |
Why?
|
| Transgenes | 3 | 2021 | 1015 | 0.590 |
Why?
|
| Inflammation | 15 | 2021 | 10863 | 0.570 |
Why?
|
| Endotoxins | 4 | 2012 | 520 | 0.570 |
Why?
|
| Gene Expression Regulation | 26 | 2022 | 11918 | 0.520 |
Why?
|
| Mice, Knockout | 25 | 2024 | 14481 | 0.510 |
Why?
|
| Lymphangioleiomyomatosis | 3 | 2022 | 207 | 0.510 |
Why?
|
| Vasoconstriction | 2 | 2009 | 594 | 0.500 |
Why?
|
| Transcriptional Activation | 14 | 2012 | 1748 | 0.490 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 2 | 2005 | 44 | 0.490 |
Why?
|
| Arteriosclerosis | 7 | 2003 | 1056 | 0.480 |
Why?
|
| Fetal Therapies | 1 | 2015 | 101 | 0.470 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 2 | 2012 | 15 | 0.460 |
Why?
|
| Cells, Cultured | 47 | 2020 | 19022 | 0.450 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2017 | 637 | 0.440 |
Why?
|
| Myopathies, Structural, Congenital | 3 | 2022 | 104 | 0.440 |
Why?
|
| Transcription Factors | 22 | 2022 | 12166 | 0.430 |
Why?
|
| Pulmonary Fibrosis | 4 | 2022 | 506 | 0.420 |
Why?
|
| Hypertension, Pulmonary | 7 | 2024 | 1597 | 0.420 |
Why?
|
| Bacteremia | 4 | 2024 | 985 | 0.420 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 318 | 0.420 |
Why?
|
| Hyaluronic Acid | 4 | 2021 | 487 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 23 | 2023 | 22355 | 0.410 |
Why?
|
| Myocytes, Cardiac | 3 | 2023 | 1685 | 0.400 |
Why?
|
| Disease Models, Animal | 19 | 2024 | 18362 | 0.400 |
Why?
|
| RNA, Messenger | 35 | 2008 | 12805 | 0.400 |
Why?
|
| Smad2 Protein | 2 | 2012 | 144 | 0.390 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 507 | 0.390 |
Why?
|
| Membrane Proteins | 20 | 2014 | 7880 | 0.390 |
Why?
|
| Enzyme Induction | 10 | 2006 | 455 | 0.390 |
Why?
|
| Aorta | 14 | 2011 | 2046 | 0.380 |
Why?
|
| NF-kappa B | 10 | 2021 | 2489 | 0.370 |
Why?
|
| Atrial Natriuretic Factor | 9 | 1994 | 350 | 0.370 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2024 | 703 | 0.370 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2010 | 38 | 0.350 |
Why?
|
| Fetal Diseases | 1 | 2015 | 916 | 0.350 |
Why?
|
| Thioredoxins | 2 | 2002 | 202 | 0.340 |
Why?
|
| MicroRNAs | 2 | 2024 | 3804 | 0.340 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.330 |
Why?
|
| Cell Line | 21 | 2024 | 15597 | 0.330 |
Why?
|
| Trophoblasts | 2 | 2021 | 223 | 0.320 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2014 | 1682 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 8 | 2020 | 6234 | 0.310 |
Why?
|
| Transfection | 14 | 2014 | 5764 | 0.310 |
Why?
|
| Parasitic Diseases | 1 | 2008 | 76 | 0.310 |
Why?
|
| Lymphangiogenesis | 3 | 2020 | 171 | 0.300 |
Why?
|
| Escherichia coli Infections | 4 | 2018 | 524 | 0.300 |
Why?
|
| Isoenzymes | 2 | 2003 | 1684 | 0.300 |
Why?
|
| Peptidoglycan | 1 | 2010 | 246 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 31 | 2024 | 8199 | 0.290 |
Why?
|
| P-Selectin | 1 | 2010 | 599 | 0.290 |
Why?
|
| Down-Regulation | 8 | 2012 | 2940 | 0.290 |
Why?
|
| Antimetabolites | 1 | 2008 | 129 | 0.280 |
Why?
|
| Carrier Proteins | 5 | 2016 | 4936 | 0.280 |
Why?
|
| HMGB1 Protein | 1 | 2008 | 141 | 0.280 |
Why?
|
| Mice, Transgenic | 10 | 2024 | 9562 | 0.280 |
Why?
|
| Rats | 41 | 2024 | 23835 | 0.280 |
Why?
|
| Myocardium | 13 | 2014 | 4788 | 0.280 |
Why?
|
| Thrombosis | 2 | 2021 | 2955 | 0.280 |
Why?
|
| Hypotension | 5 | 2018 | 889 | 0.270 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 321 | 0.270 |
Why?
|
| Trans-Activators | 8 | 2006 | 2856 | 0.270 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2020 | 86 | 0.270 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 2056 | 0.260 |
Why?
|
| Neoplasm Proteins | 4 | 2024 | 3610 | 0.250 |
Why?
|
| Fibroblasts | 8 | 2022 | 4177 | 0.250 |
Why?
|
| Lipids | 1 | 2016 | 3344 | 0.250 |
Why?
|
| Mycoses | 1 | 2008 | 386 | 0.250 |
Why?
|
| Kidney | 12 | 2004 | 7064 | 0.240 |
Why?
|
| Blotting, Western | 7 | 2014 | 5037 | 0.240 |
Why?
|
| Shock, Septic | 4 | 2007 | 774 | 0.240 |
Why?
|
| Bacteriological Techniques | 1 | 2006 | 277 | 0.240 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2021 | 3243 | 0.240 |
Why?
|
| Pulmonary Artery | 4 | 2024 | 1945 | 0.240 |
Why?
|
| Stem Cells | 5 | 2021 | 3539 | 0.230 |
Why?
|
| Hypercholesterolemia | 2 | 2001 | 1142 | 0.230 |
Why?
|
| Adenosine Triphosphate | 2 | 2023 | 2002 | 0.230 |
Why?
|
| DNA-Binding Proteins | 16 | 2022 | 9614 | 0.230 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2011 | 1368 | 0.220 |
Why?
|
| Cell Death | 4 | 2022 | 1682 | 0.220 |
Why?
|
| Blotting, Northern | 6 | 2012 | 1553 | 0.220 |
Why?
|
| Protein Binding | 12 | 2020 | 9343 | 0.220 |
Why?
|
| Nitric Oxide | 7 | 2004 | 2144 | 0.220 |
Why?
|
| Polyamines | 1 | 2024 | 133 | 0.220 |
Why?
|
| Transcription, Genetic | 15 | 2004 | 7599 | 0.220 |
Why?
|
| Mitochondria | 1 | 2017 | 3675 | 0.220 |
Why?
|
| beta Catenin | 3 | 2019 | 1047 | 0.210 |
Why?
|
| Endothelial Cells | 7 | 2020 | 3587 | 0.210 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 185 | 0.210 |
Why?
|
| Blood Vessels | 3 | 2018 | 1110 | 0.210 |
Why?
|
| Gene Silencing | 3 | 2021 | 1503 | 0.210 |
Why?
|
| Dynamin II | 1 | 2022 | 35 | 0.210 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2006 | 484 | 0.200 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2022 | 20 | 0.200 |
Why?
|
| Virus Diseases | 1 | 2008 | 723 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 3 | 2000 | 321 | 0.200 |
Why?
|
| Cytokines | 11 | 2018 | 7445 | 0.200 |
Why?
|
| Carboxypeptidases | 5 | 2009 | 121 | 0.190 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2003 | 241 | 0.190 |
Why?
|
| Hypertension, Renovascular | 1 | 2001 | 115 | 0.180 |
Why?
|
| DNA, Mitochondrial | 2 | 2023 | 871 | 0.180 |
Why?
|
| Metabolomics | 2 | 2024 | 1674 | 0.180 |
Why?
|
| Epidermal Growth Factor | 5 | 1998 | 698 | 0.180 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2002 | 173 | 0.180 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3048 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2008 | 1397 | 0.170 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2020 | 31 | 0.170 |
Why?
|
| Lung Transplantation | 3 | 2021 | 1309 | 0.170 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2000 | 72 | 0.170 |
Why?
|
| Base Sequence | 23 | 2008 | 12422 | 0.170 |
Why?
|
| Transcription Factor CHOP | 1 | 2020 | 69 | 0.170 |
Why?
|
| Cell Proliferation | 10 | 2024 | 10478 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 4 | 2001 | 4414 | 0.170 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2003 | 538 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2006 | 4526 | 0.170 |
Why?
|
| Oncogene Proteins | 2 | 2003 | 718 | 0.170 |
Why?
|
| Muscle, Skeletal | 4 | 2024 | 4981 | 0.160 |
Why?
|
| Membrane Glycoproteins | 4 | 2016 | 3712 | 0.160 |
Why?
|
| Iloprost | 2 | 2009 | 25 | 0.160 |
Why?
|
| Gene Targeting | 3 | 2008 | 841 | 0.160 |
Why?
|
| Lung Injury | 2 | 2022 | 433 | 0.160 |
Why?
|
| Myofibroblasts | 2 | 2018 | 229 | 0.160 |
Why?
|
| Signal Transduction | 11 | 2024 | 23631 | 0.150 |
Why?
|
| Molecular Sequence Data | 25 | 2008 | 17626 | 0.150 |
Why?
|
| Humans | 88 | 2024 | 768393 | 0.150 |
Why?
|
| Neutrophil Infiltration | 1 | 2021 | 395 | 0.150 |
Why?
|
| Multiple Organ Failure | 1 | 2000 | 387 | 0.150 |
Why?
|
| Respiratory Therapy | 1 | 2018 | 125 | 0.150 |
Why?
|
| Cell Polarity | 1 | 2021 | 640 | 0.150 |
Why?
|
| Endothelin-1 | 3 | 2008 | 296 | 0.150 |
Why?
|
| Endothelium, Vascular | 13 | 2004 | 4427 | 0.150 |
Why?
|
| Enzyme Inhibitors | 5 | 2009 | 3722 | 0.150 |
Why?
|
| Repressor Proteins | 8 | 2009 | 2986 | 0.150 |
Why?
|
| Atherosclerosis | 2 | 2020 | 3431 | 0.150 |
Why?
|
| Renal Circulation | 3 | 1993 | 291 | 0.140 |
Why?
|
| Acute Lung Injury | 1 | 2021 | 378 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 377 | 0.140 |
Why?
|
| Binding Sites | 9 | 2009 | 6017 | 0.140 |
Why?
|
| Recombinant Proteins | 7 | 2018 | 6510 | 0.140 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2017 | 133 | 0.140 |
Why?
|
| Cardiovascular System | 2 | 2003 | 838 | 0.140 |
Why?
|
| Salmonella typhi | 1 | 1998 | 200 | 0.140 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1994 | 149 | 0.140 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 3 | 2022 | 25 | 0.140 |
Why?
|
| Heart Failure | 10 | 2024 | 11858 | 0.140 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2022 | 3777 | 0.130 |
Why?
|
| Cardiomegaly | 2 | 2001 | 591 | 0.130 |
Why?
|
| Animals, Newborn | 4 | 2024 | 2695 | 0.130 |
Why?
|
| Tacrolimus | 1 | 2020 | 750 | 0.130 |
Why?
|
| Cyclins | 5 | 1997 | 606 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2017 | 199 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 3 | 2017 | 725 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2021 | 3612 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.130 |
Why?
|
| Apolipoproteins E | 4 | 2020 | 1459 | 0.130 |
Why?
|
| Cell Differentiation | 6 | 2020 | 11668 | 0.130 |
Why?
|
| Graft Rejection | 2 | 2021 | 4505 | 0.130 |
Why?
|
| Blood Pressure | 7 | 2008 | 8541 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 474 | 0.130 |
Why?
|
| Survival Rate | 7 | 2013 | 12870 | 0.130 |
Why?
|
| Proteins | 5 | 2004 | 6006 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1169 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2008 | 3078 | 0.120 |
Why?
|
| Liver | 2 | 2013 | 7574 | 0.120 |
Why?
|
| Immunity | 1 | 2021 | 1003 | 0.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 520 | 0.120 |
Why?
|
| Receptor, Endothelin A | 2 | 2008 | 55 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2015 | 125 | 0.120 |
Why?
|
| Neutropenia | 1 | 2020 | 893 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 118 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2018 | 4357 | 0.120 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2015 | 85 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2022 | 2460 | 0.120 |
Why?
|
| Sulfur | 1 | 2015 | 160 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2021 | 3230 | 0.120 |
Why?
|
| Cryopreservation | 1 | 2020 | 733 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2014 | 855 | 0.120 |
Why?
|
| Male | 50 | 2024 | 364902 | 0.120 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 1042 | 0.120 |
Why?
|
| Escherichia coli | 3 | 2021 | 4211 | 0.120 |
Why?
|
| Enzyme Activation | 5 | 2012 | 3587 | 0.120 |
Why?
|
| Cell Survival | 3 | 2021 | 5792 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 336 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 2911 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2014 | 69 | 0.110 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 784 | 0.110 |
Why?
|
| Collagen | 6 | 2009 | 2646 | 0.110 |
Why?
|
| Pulmonary Emphysema | 2 | 2017 | 690 | 0.110 |
Why?
|
| Vasodilator Agents | 2 | 2009 | 990 | 0.110 |
Why?
|
| Myoblasts, Cardiac | 1 | 2013 | 21 | 0.110 |
Why?
|
| Phenylephrine | 1 | 1994 | 293 | 0.110 |
Why?
|
| Myocardial Ischemia | 2 | 2002 | 2139 | 0.110 |
Why?
|
| Sp1 Transcription Factor | 4 | 2022 | 143 | 0.110 |
Why?
|
| Adipocytes | 1 | 2021 | 1200 | 0.110 |
Why?
|
| Emphysema | 1 | 2016 | 237 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 1014 | 0.110 |
Why?
|
| Up-Regulation | 8 | 2019 | 4142 | 0.110 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1993 | 43 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 945 | 0.110 |
Why?
|
| Dogs | 10 | 1994 | 3846 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 2884 | 0.110 |
Why?
|
| Bleomycin | 3 | 2022 | 493 | 0.110 |
Why?
|
| Stem Cell Factor | 1 | 2013 | 194 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2020 | 11120 | 0.110 |
Why?
|
| Interferon-gamma | 4 | 2004 | 3164 | 0.110 |
Why?
|
| Sequence Deletion | 5 | 2008 | 1497 | 0.110 |
Why?
|
| Phosphoproteins | 4 | 2004 | 2448 | 0.110 |
Why?
|
| Cathepsins | 2 | 2006 | 241 | 0.110 |
Why?
|
| Luciferases | 3 | 2004 | 712 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 1020 | 0.100 |
Why?
|
| Receptors, Angiotensin | 2 | 2022 | 141 | 0.100 |
Why?
|
| Cecum | 1 | 2013 | 231 | 0.100 |
Why?
|
| Models, Animal | 4 | 2012 | 2124 | 0.100 |
Why?
|
| Antioxidants | 2 | 2017 | 1673 | 0.100 |
Why?
|
| Bone Marrow Cells | 3 | 2013 | 2414 | 0.100 |
Why?
|
| Gene Expression | 6 | 2004 | 7598 | 0.100 |
Why?
|
| Stem Cell Transplantation | 3 | 2015 | 1602 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 3 | 2005 | 2709 | 0.100 |
Why?
|
| Uterus | 1 | 2015 | 661 | 0.100 |
Why?
|
| Peritonitis | 2 | 2011 | 368 | 0.100 |
Why?
|
| Phenotype | 6 | 2022 | 16721 | 0.090 |
Why?
|
| Cattle | 6 | 2010 | 3826 | 0.090 |
Why?
|
| Heart | 6 | 2002 | 4449 | 0.090 |
Why?
|
| Endothelial Growth Factors | 4 | 1999 | 674 | 0.090 |
Why?
|
| Neointima | 1 | 2011 | 133 | 0.090 |
Why?
|
| Pulmonary Circulation | 2 | 2000 | 744 | 0.090 |
Why?
|
| DNA | 10 | 2009 | 7211 | 0.090 |
Why?
|
| Tunica Intima | 2 | 2004 | 459 | 0.090 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 365 | 0.090 |
Why?
|
| AT Rich Sequence | 1 | 2010 | 10 | 0.090 |
Why?
|
| Cell Movement | 6 | 2022 | 5215 | 0.090 |
Why?
|
| Nuclear Proteins | 8 | 2000 | 5800 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 761 | 0.090 |
Why?
|
| Asthma | 2 | 2024 | 6280 | 0.090 |
Why?
|
| Carotid Artery Injuries | 2 | 2004 | 96 | 0.090 |
Why?
|
| Lymphokines | 4 | 1999 | 927 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 2018 | 1204 | 0.090 |
Why?
|
| Female | 24 | 2024 | 397089 | 0.090 |
Why?
|
| Genes, Reporter | 6 | 2004 | 1524 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 348 | 0.090 |
Why?
|
| Angiotensin II | 3 | 2004 | 847 | 0.090 |
Why?
|
| Cyclic GMP | 5 | 2000 | 394 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 1493 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 221 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2024 | 18048 | 0.080 |
Why?
|
| Lung Diseases | 3 | 2012 | 1925 | 0.080 |
Why?
|
| Aorta, Thoracic | 5 | 2001 | 1112 | 0.080 |
Why?
|
| Bacteria | 1 | 2021 | 2221 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 574 | 0.080 |
Why?
|
| Muscle, Smooth | 5 | 2001 | 930 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2001 | 294 | 0.080 |
Why?
|
| Netropsin | 1 | 2009 | 3 | 0.080 |
Why?
|
| HMGA Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cell Nucleus | 5 | 2019 | 2886 | 0.080 |
Why?
|
| Bronchi | 3 | 2024 | 849 | 0.080 |
Why?
|
| Biliverdine | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cloning, Molecular | 13 | 2001 | 4168 | 0.080 |
Why?
|
| Ileum | 1 | 2011 | 558 | 0.080 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 621 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2001 | 1943 | 0.080 |
Why?
|
| Homocysteine | 3 | 1997 | 637 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3695 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 311 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 669 | 0.080 |
Why?
|
| Amino Acid Sequence | 12 | 2014 | 13423 | 0.080 |
Why?
|
| Sp3 Transcription Factor | 2 | 2011 | 30 | 0.080 |
Why?
|
| Femoral Artery | 2 | 2011 | 829 | 0.080 |
Why?
|
| Pregnancy | 2 | 2023 | 30200 | 0.080 |
Why?
|
| DNA Primers | 7 | 1999 | 2825 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1151 | 0.070 |
Why?
|
| Traction | 1 | 2008 | 111 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1755 | 0.070 |
Why?
|
| Myocardial Infarction | 7 | 2006 | 11516 | 0.070 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2008 | 109 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2018 | 2929 | 0.070 |
Why?
|
| Dexamethasone | 2 | 1996 | 1965 | 0.070 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2004 | 69 | 0.070 |
Why?
|
| Arachidonic Acid | 1 | 2009 | 429 | 0.070 |
Why?
|
| Endothelins | 3 | 1992 | 127 | 0.070 |
Why?
|
| Gels | 1 | 2008 | 421 | 0.070 |
Why?
|
| Aging | 3 | 2017 | 8764 | 0.070 |
Why?
|
| Aortic Aneurysm | 1 | 1991 | 649 | 0.070 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 558 | 0.070 |
Why?
|
| Gelsolin | 1 | 2007 | 189 | 0.070 |
Why?
|
| Enterococcus faecalis | 1 | 2008 | 244 | 0.070 |
Why?
|
| Retina | 1 | 2017 | 2661 | 0.070 |
Why?
|
| Protein Stability | 2 | 2019 | 580 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2018 | 3334 | 0.060 |
Why?
|
| omega-N-Methylarginine | 4 | 1994 | 108 | 0.060 |
Why?
|
| Arginine | 4 | 1994 | 923 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2008 | 597 | 0.060 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2008 | 342 | 0.060 |
Why?
|
| Receptors, Growth Factor | 2 | 1996 | 326 | 0.060 |
Why?
|
| Bilirubin | 1 | 2007 | 438 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2013 | 2611 | 0.060 |
Why?
|
| Spermine | 1 | 2004 | 70 | 0.060 |
Why?
|
| Calcium | 1 | 2018 | 5794 | 0.060 |
Why?
|
| Heme | 1 | 2007 | 316 | 0.060 |
Why?
|
| Acetylcysteine | 2 | 2016 | 262 | 0.060 |
Why?
|
| Pulmonary Surfactants | 1 | 2005 | 169 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2004 | 32 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2004 | 65 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2004 | 30 | 0.060 |
Why?
|
| Surface Tension | 1 | 2004 | 43 | 0.060 |
Why?
|
| Loop of Henle | 1 | 2004 | 38 | 0.060 |
Why?
|
| Transduction, Genetic | 2 | 2004 | 902 | 0.060 |
Why?
|
| Culture Media, Conditioned | 2 | 2023 | 521 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2004 | 216 | 0.060 |
Why?
|
| Dactinomycin | 2 | 1994 | 305 | 0.060 |
Why?
|
| Time Factors | 13 | 2017 | 40272 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2004 | 220 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2004 | 2673 | 0.060 |
Why?
|
| Hemodynamics | 6 | 1994 | 4199 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2004 | 244 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2024 | 8326 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2006 | 715 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2004 | 1142 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2008 | 1208 | 0.050 |
Why?
|
| Lymphatic Vessels | 2 | 2019 | 356 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2013 | 2938 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2001 | 279 | 0.050 |
Why?
|
| Dimerization | 2 | 2001 | 886 | 0.050 |
Why?
|
| Kinetics | 8 | 2002 | 6333 | 0.050 |
Why?
|
| Cell Communication | 1 | 2010 | 1660 | 0.050 |
Why?
|
| Albinism | 1 | 2022 | 25 | 0.050 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2022 | 21 | 0.050 |
Why?
|
| Smoking | 2 | 2017 | 9111 | 0.050 |
Why?
|
| Hemorrhagic Disorders | 1 | 2022 | 34 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1731 | 0.050 |
Why?
|
| Cholesterol | 2 | 2001 | 2912 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 962 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2024 | 238 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 492 | 0.050 |
Why?
|
| Ribotyping | 1 | 2021 | 35 | 0.050 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2001 | 18 | 0.050 |
Why?
|
| Metalloendopeptidases | 2 | 2000 | 385 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2004 | 2299 | 0.050 |
Why?
|
| Dependovirus | 2 | 2004 | 721 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1086 | 0.050 |
Why?
|
| Insulin | 3 | 2008 | 6607 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 432 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 595 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 3434 | 0.050 |
Why?
|
| Aerosols | 1 | 2004 | 637 | 0.050 |
Why?
|
| Carboxyhemoglobin | 2 | 2018 | 83 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9510 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2021 | 2066 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2000 | 501 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 1890 | 0.050 |
Why?
|
| Lung Diseases, Fungal | 1 | 2021 | 124 | 0.050 |
Why?
|
| DNA, Complementary | 6 | 2004 | 1992 | 0.050 |
Why?
|
| Carbon-Oxygen Lyases | 1 | 2000 | 8 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 97 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2002 | 276 | 0.050 |
Why?
|
| Models, Biological | 4 | 2008 | 9493 | 0.040 |
Why?
|
| Myocardial Reperfusion | 1 | 2002 | 339 | 0.040 |
Why?
|
| Losartan | 1 | 2022 | 263 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 2001 | 172 | 0.040 |
Why?
|
| Genetic Vectors | 3 | 2004 | 3413 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1605 | 0.040 |
Why?
|
| Molecular Weight | 3 | 2015 | 2172 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2000 | 583 | 0.040 |
Why?
|
| Proteomics | 2 | 2024 | 3906 | 0.040 |
Why?
|
| Renal Artery Obstruction | 1 | 2001 | 218 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2008 | 9379 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2001 | 10776 | 0.040 |
Why?
|
| Apoptosis | 5 | 2020 | 9516 | 0.040 |
Why?
|
| Sequence Alignment | 4 | 2014 | 2176 | 0.040 |
Why?
|
| Homeostasis | 2 | 2006 | 3349 | 0.040 |
Why?
|
| Syntenins | 1 | 2019 | 8 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2004 | 722 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2001 | 2588 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 412 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2004 | 872 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2002 | 518 | 0.040 |
Why?
|
| Cyclin A | 1 | 1999 | 60 | 0.040 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2024 | 365 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 665 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2006 | 1410 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2000 | 287 | 0.040 |
Why?
|
| Maleimides | 1 | 2019 | 112 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2022 | 2812 | 0.040 |
Why?
|
| Organ Size | 2 | 2001 | 2268 | 0.040 |
Why?
|
| Neuroglia | 1 | 2004 | 960 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2011 | 293 | 0.040 |
Why?
|
| Cell Division | 4 | 2001 | 4479 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1996 | 1628 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1996 | 826 | 0.040 |
Why?
|
| Zinc Fingers | 2 | 1998 | 577 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 7 | 1996 | 6085 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2020 | 393 | 0.040 |
Why?
|
| E-Selectin | 1 | 2000 | 578 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 1281 | 0.040 |
Why?
|
| Umbilical Veins | 5 | 1997 | 425 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 254 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 3 | 2011 | 254 | 0.040 |
Why?
|
| Iron | 1 | 2006 | 1814 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2006 | 2771 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2000 | 556 | 0.040 |
Why?
|
| Fungal Proteins | 2 | 1999 | 906 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2001 | 2094 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 384 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2021 | 677 | 0.040 |
Why?
|
| Consensus Sequence | 4 | 2002 | 363 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2017 | 71 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1136 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 15649 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2022 | 540 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2011 | 617 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 1997 | 170 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 2069 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2017 | 136 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2000 | 3088 | 0.030 |
Why?
|
| Thiocarbamates | 1 | 1996 | 30 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2017 | 2574 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1998 | 306 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 415 | 0.030 |
Why?
|
| Homozygote | 1 | 2001 | 1779 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2016 | 99 | 0.030 |
Why?
|
| Lectins | 1 | 1998 | 490 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2016 | 207 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 286 | 0.030 |
Why?
|
| Smad3 Protein | 3 | 2000 | 166 | 0.030 |
Why?
|
| Natriuresis | 2 | 1993 | 105 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2001 | 949 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 633 | 0.030 |
Why?
|
| Multipotent Stem Cells | 1 | 2017 | 200 | 0.030 |
Why?
|
| Biological Transport | 1 | 2020 | 2085 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1084 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 1998 | 1658 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 1033 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2022 | 65379 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 1999 | 750 | 0.030 |
Why?
|
| Creatinine | 1 | 2001 | 1915 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1997 | 611 | 0.030 |
Why?
|
| Vascular Resistance | 3 | 1994 | 940 | 0.030 |
Why?
|
| Telomerase | 1 | 2020 | 752 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13576 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1993 | 862 | 0.030 |
Why?
|
| Diuresis | 2 | 1993 | 106 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 2726 | 0.030 |
Why?
|
| Thorax | 1 | 2018 | 559 | 0.030 |
Why?
|
| Microvessels | 1 | 2019 | 586 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 1994 | 98 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2001 | 1019 | 0.030 |
Why?
|
| Mutation | 5 | 2015 | 30228 | 0.030 |
Why?
|
| Calcinosis | 1 | 2003 | 1481 | 0.030 |
Why?
|
| Heterozygote | 1 | 2001 | 2791 | 0.030 |
Why?
|
| Drosophila | 2 | 1999 | 1514 | 0.030 |
Why?
|
| Vasodilation | 1 | 1998 | 968 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 164 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1992 | 657 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1994 | 342 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 1996 | 340 | 0.030 |
Why?
|
| Nitrites | 1 | 1994 | 156 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 1131 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2632 | 0.030 |
Why?
|
| Turkey | 1 | 2014 | 256 | 0.030 |
Why?
|
| Myofibrils | 1 | 2014 | 143 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 585 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2014 | 201 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2018 | 739 | 0.030 |
Why?
|
| Triglycerides | 1 | 2001 | 2465 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 461 | 0.030 |
Why?
|
| Ventricular Function | 2 | 2006 | 406 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 1994 | 517 | 0.030 |
Why?
|
| Macaca | 1 | 2014 | 417 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 1993 | 99 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2001 | 1901 | 0.030 |
Why?
|
| Acute Disease | 2 | 2015 | 7242 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 1998 | 1135 | 0.030 |
Why?
|
| Cysteine | 1 | 1997 | 895 | 0.030 |
Why?
|
| Genotype | 2 | 2011 | 13042 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 968 | 0.030 |
Why?
|
| Cell Adhesion | 3 | 2009 | 3102 | 0.030 |
Why?
|
| Pneumonia | 1 | 2024 | 2163 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 1998 | 844 | 0.020 |
Why?
|
| Punctures | 1 | 2013 | 372 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 16028 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2021 | 5151 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1726 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 1998 | 2750 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1667 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2017 | 3442 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1997 | 1532 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2058 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 3407 | 0.020 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2000 | 44 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3633 | 0.020 |
Why?
|
| Indoles | 1 | 2019 | 1825 | 0.020 |
Why?
|
| Prednisone | 1 | 2015 | 1567 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 1991 | 363 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 375 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 2 | 2001 | 97 | 0.020 |
Why?
|
| Zebrafish | 1 | 2022 | 3037 | 0.020 |
Why?
|
| Heart Ventricles | 3 | 2006 | 3838 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 525 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1999 | 4120 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1820 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2003 | 10117 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2001 | 1141 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 1836 | 0.020 |
Why?
|
| Wound Healing | 1 | 2001 | 2813 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 254 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 1034 | 0.020 |
Why?
|
| Spleen | 1 | 1996 | 2296 | 0.020 |
Why?
|
| Pulmonary Medicine | 1 | 2012 | 223 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1998 | 706 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1994 | 1207 | 0.020 |
Why?
|
| In Situ Hybridization | 3 | 2000 | 1905 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2024 | 26411 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 439 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 1766 | 0.020 |
Why?
|
| Octamer Transcription Factors | 1 | 2009 | 18 | 0.020 |
Why?
|
| Mortality | 1 | 2000 | 2917 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1195 | 0.020 |
Why?
|
| Transition Temperature | 1 | 2009 | 33 | 0.020 |
Why?
|
| Alanine | 1 | 1991 | 613 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 835 | 0.020 |
Why?
|
| Neprilysin | 1 | 1991 | 487 | 0.020 |
Why?
|
| Age Factors | 2 | 2016 | 18471 | 0.020 |
Why?
|
| PC12 Cells | 2 | 2001 | 317 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1608 | 0.020 |
Why?
|
| Adult | 7 | 2024 | 223640 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12456 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2008 | 198 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 4622 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1999 | 2144 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2015 | 2204 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2742 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1992 | 1081 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 1671 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 2002 | 3125 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1991 | 752 | 0.020 |
Why?
|
| Hormones | 1 | 1991 | 870 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 4775 | 0.020 |
Why?
|
| Angioplasty, Balloon | 2 | 2004 | 592 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1991 | 577 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2001 | 6430 | 0.020 |
Why?
|
| Activating Transcription Factor 1 | 2 | 1997 | 26 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2429 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 508 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 1999 | 3520 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 915 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 7463 | 0.020 |
Why?
|
| Vascular Diseases | 2 | 2006 | 1161 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 2724 | 0.020 |
Why?
|
| Thymidine | 2 | 1996 | 297 | 0.020 |
Why?
|
| Reactive Nitrogen Species | 1 | 2004 | 35 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2004 | 129 | 0.010 |
Why?
|
| Indomethacin | 2 | 1996 | 323 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 126 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3794 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22296 | 0.010 |
Why?
|
| Disease Progression | 1 | 2021 | 13646 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2006 | 268 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1753 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 808 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 3779 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 612 | 0.010 |
Why?
|
| Ischemia | 1 | 1992 | 1900 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 4588 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3731 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 874 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 587 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 2004 | 175 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15939 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8634 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2002 | 22 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4209 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 1409 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 1996 | 664 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8753 | 0.010 |
Why?
|
| Regeneration | 1 | 2011 | 1525 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1991 | 1414 | 0.010 |
Why?
|
| Mesoderm | 1 | 2004 | 679 | 0.010 |
Why?
|
| Retroviridae | 1 | 2004 | 849 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1992 | 2103 | 0.010 |
Why?
|
| Cytoprotection | 1 | 2002 | 200 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 839 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2001 | 238 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 447 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 706 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2004 | 1153 | 0.010 |
Why?
|
| Synaptotagmin I | 1 | 2000 | 33 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 2514 | 0.010 |
Why?
|
| Synaptotagmins | 1 | 2000 | 53 | 0.010 |
Why?
|
| Response Elements | 1 | 2002 | 308 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 527 | 0.010 |
Why?
|
| Alleles | 1 | 2011 | 6892 | 0.010 |
Why?
|
| Renin | 2 | 1994 | 648 | 0.010 |
Why?
|
| Time | 1 | 2002 | 546 | 0.010 |
Why?
|
| Protein Conformation | 2 | 1998 | 3955 | 0.010 |
Why?
|
| Biopsy | 1 | 1992 | 6808 | 0.010 |
Why?
|
| Actins | 1 | 2007 | 2059 | 0.010 |
Why?
|
| Blood Circulation | 1 | 2000 | 248 | 0.010 |
Why?
|
| Skin | 2 | 2004 | 4499 | 0.010 |
Why?
|
| Echocardiography | 1 | 1992 | 5044 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1999 | 155 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2001 | 414 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 1999 | 193 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1674 | 0.010 |
Why?
|
| Fibrosis | 1 | 2006 | 2077 | 0.010 |
Why?
|
| Artificial Gene Fusion | 1 | 1998 | 56 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1999 | 313 | 0.010 |
Why?
|
| Serum Response Factor | 1 | 1998 | 78 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 1999 | 210 | 0.010 |
Why?
|
| Bone Development | 1 | 2001 | 473 | 0.010 |
Why?
|
| Lac Operon | 1 | 1998 | 237 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1991 | 6001 | 0.010 |
Why?
|
| Mink | 1 | 1997 | 31 | 0.010 |
Why?
|
| Genes, fos | 1 | 1998 | 176 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1997 | 67 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1997 | 79 | 0.010 |
Why?
|
| Neurons | 1 | 2017 | 9513 | 0.010 |
Why?
|
| S-Adenosylhomocysteine | 1 | 1997 | 40 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 4781 | 0.010 |
Why?
|
| Spine | 1 | 2004 | 1141 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 274 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1999 | 527 | 0.010 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 1999 | 221 | 0.010 |
Why?
|
| Aged | 3 | 2018 | 171562 | 0.010 |
Why?
|
| Anisomycin | 1 | 1996 | 27 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 315 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2001 | 724 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 288 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1997 | 257 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 96 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 1996 | 61 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 1526 | 0.010 |
Why?
|
| Protamine Kinase | 1 | 1996 | 12 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1996 | 189 | 0.010 |
Why?
|
| G1 Phase | 1 | 1997 | 403 | 0.010 |
Why?
|
| Activating Transcription Factors | 1 | 1996 | 30 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1996 | 148 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4250 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1998 | 534 | 0.010 |
Why?
|
| Neural Crest | 1 | 1998 | 279 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1997 | 591 | 0.010 |
Why?
|
| TATA Box | 1 | 1995 | 127 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 1999 | 623 | 0.010 |
Why?
|
| Contact Inhibition | 1 | 1995 | 46 | 0.010 |
Why?
|
| Genomic Library | 1 | 1995 | 188 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1999 | 664 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1337 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 3055 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 484 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1996 | 323 | 0.010 |
Why?
|
| Reference Values | 2 | 1994 | 4941 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 849 | 0.010 |
Why?
|
| Growth Substances | 1 | 1997 | 761 | 0.010 |
Why?
|
| Methylation | 1 | 1997 | 1076 | 0.010 |
Why?
|
| Catheterization | 1 | 1999 | 1431 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2636 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1994 | 154 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 214 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1994 | 176 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1994 | 310 | 0.010 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 1993 | 20 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 2 | 1993 | 2226 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1996 | 595 | 0.010 |
Why?
|
| Dinoprost | 1 | 1994 | 139 | 0.010 |
Why?
|
| Staurosporine | 1 | 1994 | 241 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 1739 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 1994 | 150 | 0.010 |
Why?
|
| Alkaloids | 1 | 1994 | 192 | 0.010 |
Why?
|
| Blood | 1 | 1996 | 597 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1996 | 1163 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1996 | 812 | 0.010 |
Why?
|
| Phylogeny | 1 | 2000 | 2843 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1994 | 422 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 1997 | 943 | 0.010 |
Why?
|
| Constriction | 1 | 1992 | 168 | 0.010 |
Why?
|
| Middle Aged | 3 | 2018 | 223491 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1994 | 453 | 0.010 |
Why?
|
| Half-Life | 1 | 1993 | 650 | 0.010 |
Why?
|
| Renal Artery | 1 | 1994 | 353 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1998 | 1614 | 0.010 |
Why?
|
| Azepines | 1 | 1994 | 329 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2433 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 629 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1996 | 1762 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 1967 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 41795 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 1229 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42650 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1994 | 838 | 0.010 |
Why?
|
| Monocytes | 1 | 2000 | 2595 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 30022 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1996 | 1078 | 0.010 |
Why?
|
| Ligands | 1 | 1997 | 3283 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 204 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1996 | 1186 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 4834 | 0.010 |
Why?
|
| DNA Replication | 1 | 1996 | 1428 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1997 | 3663 | 0.000 |
Why?
|
| Fetus | 1 | 1995 | 1883 | 0.000 |
Why?
|
| Heart Atria | 1 | 1993 | 1360 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1997 | 5900 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1992 | 863 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 59686 | 0.000 |
Why?
|
| Sodium | 1 | 1991 | 1594 | 0.000 |
Why?
|
| Child | 1 | 2014 | 80891 | 0.000 |
Why?
|
| Bronchoscopy | 1 | 1992 | 913 | 0.000 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 1993 | 1751 | 0.000 |
Why?
|
| Chromatin | 1 | 1996 | 2968 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1991 | 36849 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1990 | 6350 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 11254 | 0.000 |
Why?
|